Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1388320/000121390020022334/f10q0620_actiniumpharma.htm
December 2023
March 2023
February 2023
December 2022
December 2022
October 2022
June 2022
April 2022
November 2021
September 2021
Document and Entity Information - shares | 6 Months Ended | |
---|---|---|
Jun. 30, 2020 | Aug. 13, 2020 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Actinium Pharmaceuticals, Inc. | |
Entity Central Index Key | 0001388320 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Type | 10-Q | |
Document Period End Date | Jun. 30, 2020 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2020 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Shell Company | false | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Common Stock, Shares Outstanding | 13,585,222 | |
Entity File Number | 001-36374 | |
Entity Interactive Data Current | Yes | |
Entity Incorporation State Country Code | DE |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1388320/000121390020022334/f10q0620_actiniumpharma.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Actinium Pharmaceuticals, Inc..
Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ATNM
CIK: 1388320
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-20-022334
Submitted to the SEC: Fri Aug 14 2020 5:16:18 PM EST
Accepted by the SEC: Fri Aug 14 2020
Period: Tuesday, June 30, 2020
Industry: Pharmaceutical Preparations